# AIM (Aim Immunotech Inc.) - SEC EDGAR Financial Statements

> Aim Immunotech Inc. reported $91K in revenue and a net loss of $14.13M for the trailing twelve months ended September 30, 2026 (down 15.4% year over year), with a -12800.0% operating margin.

- Canonical: https://convexityos.com/fundamentals/AIM
- Markdown: https://convexityos.com/fundamentals/AIM.md
- SEC CIK: 0000946644
- Reporting currency: USD
- Latest filing period: September 30, 2026
- Last synced: Nov 21, 2026, 05:09 UTC
- Primary source: [SEC EDGAR](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0000946644&type=&dateb=&owner=include&count=40)

## Key Financial Metrics

| Metric | Period | Value | Notes |
| --- | --- | --- | --- |
| Revenue | TTM | $91K | -15.4% YoY |
| Operating Income | TTM | -$11.65M | -12800.0% margin |
| Net Income | TTM | -$14.13M | -15526.4% net margin |
| Diluted EPS | TTM | -$0.43 | Split-adjusted |
| Free Cash Flow | TTM | -- | Operating CF less CapEx |
| Cash & ST Investments | Sep 30, 2026 | $6.95M | Total debt: $1.67M |

## Income Statement

### Income Statement (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Revenue** | $88K | $170K | $202K | $141K | $135K | $163K | $140K | $367K | $437K | $92K |
| Research & Development | $3.92M | $6.20M | $10.94M | $6.99M | $7.67M | $5.72M | $4.65M | $4.78M | $4.10M | $5.11M |
| **Operating Income** | -$11.66M | -$19.77M | -$31.92M | -$19.92M | -$18.84M | -$15.15M | -$12.44M | -$11.50M | -$11.42M | -$13.80M |
| **EBITDA** | -$11.45M | -$19.43M | -$31.68M | -$19.67M | -$18.06M | -$14.42M | -$11.65M | -$10.62M | -$10.41M | -$12.63M |
| Interest Expense | $812K | $585K | -- | -- | $67K | $672K | $427K | $201K | $139K | -- |
| Income Before Tax | -$13.96M | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| **Net Income** | -$13.96M | -$17.32M | -$28.96M | -$19.45M | -$19.13M | -$14.40M | -$9.40M | -$9.83M | -$8.26M | -$7.50M |
| Basic EPS | -$8.62 | -$30.92 | -$60.00 | -$40.00 | -$40.00 | -$45.00 | -$258.00 | -$977.00 | -$29.00 | -$34.00 |
| **Diluted EPS** | -$8.62 | -$30.92 | -$60.00 | -$40.00 | -$40.00 | -$45.00 | -$258.00 | -$977.00 | -$29.00 | -$34.00 |
| Basic Shares Outstanding | 1.6M | 560.2K | 485.9K | -- | 473.4K | 318.4K | 36.4K | 10.0K | 286.8K | 218.2K |
| Diluted Shares Outstanding | 1.6M | 560.2K | 485.9K | 480.5K | 473.4K | 318.4K | 36.4K | 10.0K | 286.8K | 218.2K |

### Income Statement (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Revenue** | $22K | $26K | $22K | $21K | $26K | $25K | $16K | $45K |
| Research & Development | $846K | $589K | $482K | $1.06M | $607K | $1.17M | $1.08M | $1.66M |
| **Operating Income** | -$2.96M | -$3.51M | -$2.23M | -$2.95M | -$2.45M | -$2.65M | -$3.62M | -$5.86M |
| **EBITDA** | -$2.91M | -$3.47M | -$2.18M | -$2.91M | -$2.39M | -$2.59M | -$3.56M | -$5.78M |
| Interest Expense | $259K | $295K | $304K | -$42K | $581K | $149K | $124K | $132K |
| **Net Income** | -$3.14M | -$3.79M | -$3.02M | -$4.17M | -$3.28M | -$2.79M | -$3.71M | -$5.97M |
| Basic EPS | -$0.21 | -$0.43 | -$0.69 | -- | -$1.57 | -$3.68 | -$0.05 | -- |
| **Diluted EPS** | -$0.21 | -$0.43 | -$0.69 | -- | -$1.57 | -$3.68 | -$0.05 | -- |
| Basic Shares Outstanding | 32.5M | 17.1M | 4.4M | -- | 2.1M | 759.3K | 703.3K | -- |
| Diluted Shares Outstanding | 32.5M | 17.1M | 4.4M | -- | 2.1M | 759.3K | 703.3K | -- |

## Balance Sheet

### Balance Sheet (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Cash & Cash Equivalents | $2.98M | $1.70M | $5.44M | $27.05M | $32.09M | $38.50M | $1.47M | $299K | $1.41M | $2.41M |
| Short-Term Investments | $62K | $2.28M | $7.63M | $7.14M | $16.18M | $15.88M | $7.31M | -- | -- | -- |
| **Cash & Short-Term Investments** | $3.05M | $3.98M | $13.07M | $34.19M | $48.27M | $54.38M | $8.78M | $299K | $1.41M | $2.41M |
| Accounts Receivable, Net | $7.0K | -- | $1.18M | $1.68M | -- | $34K | $44K | $235K | $24K | -- |
| **Total Current Assets** | $3.29M | $4.18M | $14.56M | $36.32M | $50.21M | $40.31M | $10.45M | $3.80M | $3.50M | $6.94M |
| Property, Plant & Equipment, Net | $71K | $108K | $127K | $195K | $4.05M | $6.47M | $7.12M | $7.78M | $8.59M | $9.51M |
| Intangible Assets | $1.66M | $2.59M | $2.31M | $1.94M | $1.97M | $1.50M | $1.15M | $911K | $858K | $872K |
| Long-Term Investments | -- | -- | -- | -- | -- | $15.38M | -- | -- | -- | -- |
| Other Non-Current Assets | $377K | $1.11M | $1.69M | $1.20M | $1.32M | $748K | $1.89M | $1.35M | $1.26M | $1.55M |
| **Total Non-Current Assets** | $2.49M | $4.43M | $4.83M | $4.17M | $7.49M | $24.27M | $10.31M | $10.05M | $10.70M | $11.93M |
| **Total Assets** | $5.78M | $8.61M | $19.38M | $40.49M | $57.70M | $64.58M | $20.75M | $13.85M | $14.21M | $18.87M |
| Accounts Payable | $1.63M | $6.38M | $6.44M | $377K | $198K | $383K | $472K | $680K | $741K | $887K |
| Short-Term Debt | $3.55M | $2.31M | -- | -- | -- | $230K | $214K | $199K | -- | -- |
| **Total Current Liabilities** | $6.22M | $9.54M | $8.65M | $1.36M | $673K | $1.10M | $1.13M | $5.29M | $2.71M | $2.44M |
| Long-Term Debt | $927K | $500K | -- | -- | -- | $1.88M | $2.10M | $2.32M | -- | -- |
| **Total Non-Current Liabilities** | $9.34M | $395K | $495K | $659K | $147K | $2.19M | $6.18M | $2.97M | $2.80M | $940K |
| **Total Liabilities** | $15.56M | $9.93M | $9.15M | $2.02M | $820K | $3.29M | $7.31M | $8.27M | $5.50M | $3.38M |
| **Total Debt (incl. Leases)** | $4.90M | $3.44M | $718K | $837K | $149K | $2.29M | $2.48M | $2.52M | -- | -- |
| Common Stock | $3.0K | $1.0K | $49K | $48K | $48K | $42K | $10K | $1.0K | $33K | $24K |
| Retained Earnings | -$440.8M | -$426.8M | -$409.5M | -$380.5M | -$361.1M | -$342.0M | -$327.6M | -$318.6M | -$308.8M | -$300.5M |
| Accumulated Other Comp. Income | -- | -- | -- | -- | -- | -$47K | -- | -- | -- | -- |
| **Total Stockholders' Equity** | -$9.78M | -$1.32M | $10.23M | $38.47M | $56.88M | $61.29M | $13.44M | $5.58M | $8.70M | $15.50M |
| Total Equity | -$9.78M | -$1.32M | $10.23M | $38.47M | $56.88M | $61.29M | $13.44M | $5.58M | $8.70M | $15.50M |

### Balance Sheet (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Cash & Cash Equivalents | $6.89M | $9.90M | $5.82M | $2.98M | $2.35M | $476K | $898K | $1.70M |
| Short-Term Investments | $61K | $64K | $63K | $62K | $62K | $359K | $1.35M | $2.28M |
| **Cash & Short-Term Investments** | $6.95M | $9.96M | $5.88M | $3.05M | $2.41M | $835K | $2.25M | $3.98M |
| Accounts Receivable, Net | -- | -- | -- | $7.0K | -- | -- | -- | -- |
| **Total Current Assets** | $7.34M | $10.43M | $6.21M | $3.29M | $2.58M | $1.02M | $2.58M | $4.18M |
| Property, Plant & Equipment, Net | $49K | $54K | $62K | $71K | $80K | $89K | $98K | $108K |
| Intangible Assets | $1.76M | $1.71M | $1.66M | $1.66M | $2.04M | $2.17M | $2.27M | $2.59M |
| Other Non-Current Assets | $407K | $271K | $327K | $377K | $362K | $351K | $745K | $1.11M |
| **Total Non-Current Assets** | $2.42M | $2.30M | $2.37M | $2.49M | $2.92M | $3.10M | $3.66M | $4.43M |
| **Total Assets** | $9.75M | $12.73M | $8.59M | $5.78M | $5.49M | $4.13M | $6.25M | $8.61M |
| Accounts Payable | $443K | $480K | $1.22M | $1.63M | $1.25M | $7.30M | $6.94M | $6.38M |
| Short-Term Debt | $1.44M | $3.62M | $4.00M | $3.55M | $1.88M | $2.29M | $1.95M | $2.31M |
| **Total Current Liabilities** | $2.67M | $4.95M | $6.14M | $6.22M | $4.04M | $10.39M | $9.77M | $9.54M |
| Long-Term Debt | $0 | $0 | $210K | $927K | -- | $431K | $436K | $500K |
| **Total Non-Current Liabilities** | $3.0K | $41K | $315K | $9.34M | $7.53M | $282K | $338K | $395K |
| **Total Liabilities** | $2.67M | $4.99M | $6.46M | $15.56M | $11.57M | $10.68M | $10.11M | $9.93M |
| **Total Debt (incl. Leases)** | $1.67M | $3.92M | $4.57M | $4.90M | $2.34M | $3.24M | $2.96M | $3.44M |
| Common Stock | $40K | $29K | $8.0K | $3.0K | $3.0K | $1.0K | $72K | $1.0K |
| Retained Earnings | -$450.7M | -$447.6M | -$443.8M | -$440.8M | -$436.6M | -$433.3M | -$430.5M | -$426.8M |
| **Total Stockholders' Equity** | $7.08M | $7.74M | $2.12M | -$9.78M | -$6.08M | -$6.55M | -$3.86M | -$1.32M |
| Total Equity | $7.08M | $7.74M | $2.12M | -$9.78M | -$6.08M | -$6.55M | -$3.86M | -$1.32M |

## Cash Flow Statement

### Cash Flow Statement (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Net Income | -$13.96M | -$17.32M | -$28.96M | -$19.45M | -$19.13M | -$14.40M | -$9.40M | -$9.83M | -$8.26M | -$7.50M |
| Depreciation & Amortization | $210K | $339K | $238K | $256K | $775K | $733K | $792K | $878K | $1.00M | $1.17M |
| Stock-Based Compensation | $60K | $686K | $243K | $954K | $1.57M | $1.04M | $853K | $929K | $571K | $52K |
| Change in Receivables | -- | $1.18M | $492K | -$35K | $34K | $40K | -$191K | -$1.07M | -$24K | -- |
| Change in Payables | -$1.71M | -$60K | $6.07M | $179K | -$185K | -$89K | -$207K | $166K | $566K | -$326K |
| **Operating Cash Flow** | -$10.96M | -$14.89M | -$21.27M | -$16.11M | -$13.96M | -$10.37M | -$9.07M | -$10.64M | -$7.94M | -$7.38M |
| Capital Expenditure | -- | -$18K | -- | -$86K | -$41K | -$22K | -$68K | -$51K | -$20K | -$160K |
| **Free Cash Flow** | -- | -$14.91M | -- | -$16.19M | -$14.01M | -$10.39M | -$9.13M | -$10.69M | -$7.96M | -$7.54M |
| Purchases of Investments | -$91K | -$361K | -$1.59M | -$2.72M | -$22.54M | -$18.61M | -$5.78M | -- | -- | -- |
| **Investing Cash Flow** | $1.85M | $4.71M | -$832K | $10.99M | -$631K | -$9.16M | -$6.15M | $92K | $2.73M | $2.92M |
| Common Stock Issued | -- | $892K | $485K | $80K | $13.04M | $61.25M | $15.30M | $5.07M | $2.42M | $4.74M |
| **Financing Cash Flow** | $10.39M | $6.44M | $485K | $80K | $8.19M | $56.56M | $16.39M | $9.44M | $4.21M | $4.76M |
| **Net Change in Cash** | $1.28M | -$3.74M | -$21.61M | -$5.04M | -$6.41M | $37.03M | $1.17M | -$1.11M | -$996K | $293K |

### Cash Flow Statement (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Net Income | -$3.14M | -$3.79M | -$3.02M | -$4.17M | -$3.28M | -$2.79M | -$3.71M | -$5.97M |
| Depreciation & Amortization | $43K | $44K | $43K | $43K | $54K | $55K | $58K | $79K |
| Stock-Based Compensation | -- | $0 | $0 | $0 | $0 | $0 | $60K | $196K |
| Change in Receivables | -- | -- | -- | -- | -- | -- | -- | $3.0K |
| Change in Payables | -- | -- | -$415K | -$56K | -$2.57M | $353K | $561K | $119K |
| **Operating Cash Flow** | -$2.93M | -$4.59M | -$2.72M | -$1.99M | -$5.08M | -$1.53M | -$2.36M | -$3.96M |
| Purchases of Investments | $0 | $0 | -$6.0K | $0 | $0 | $0 | -$91K | -$203K |
| **Investing Cash Flow** | -$83K | -$112K | -$37K | -$95K | $296K | $754K | $898K | $3.70M |
| Common Stock Issued | $0 | $537K | $2.00M | -- | -$398K | $105K | $660K | $32K |
| **Financing Cash Flow** | $1.0K | $8.79M | $5.59M | $2.72M | $6.65M | $355K | $660K | $1.04M |
| **Net Change in Cash** | -$3.01M | $4.08M | $2.83M | $638K | $1.87M | -$422K | -$803K | $786K |

## Profitability Ratios & YoY Growth

### Profitability Ratios & YoY Growth (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Operating Margin** | -13254.5% | -11630.6% | -15800.0% | -14129.8% | -13954.1% | -9295.7% | -8887.9% | -3132.4% | -2612.4% | -15004.3% |
| **Net Profit Margin** | -15861.4% | -10188.2% | -14337.6% | -13790.8% | -14168.1% | -8834.4% | -6717.1% | -2677.7% | -1889.9% | -8154.3% |
| Return on Equity (ROE) | -- | -- | -283.0% | -50.5% | -33.6% | -23.5% | -70.0% | -176.1% | -94.9% | -48.4% |
| Return on Assets (ROA) | -241.4% | -201.2% | -149.4% | -48.0% | -33.1% | -22.3% | -45.3% | -71.0% | -58.1% | -39.7% |
| Current Ratio | 0.53x | 0.44x | 1.68x | 26.69x | 74.61x | 36.58x | 9.27x | 0.72x | 1.29x | 2.85x |
| Quick Ratio | 0.49x | 0.42x | 1.65x | 26.35x | 71.72x | 49.38x | 7.83x | 0.10x | 0.53x | 0.99x |
| Debt to Equity | -- | -- | 0.07x | 0.02x | 0.00x | 0.04x | 0.18x | 0.45x | -- | -- |
| **Revenue Growth (YoY)** | -48.2% | -15.8% | +43.3% | +4.4% | -17.2% | +16.4% | -61.9% | -16.0% | +375.0% | -30.8% |
| 5Y Revenue / Share Growth | -89.4% | -92.1% | -98.9% | -- | -32.4% | -24.3% | +206.1% | +40663.7% | +908.9% | +254.7% |
| 10Y Revenue / Share Growth | -92.0% | -75.8% | +363.8% | -- | +139.9% | +408.2% | -- | -- | -- | -- |

### Profitability Ratios & YoY Growth (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Operating Margin** | -12800.0% | -11724.2% | -10926.6% | -13254.5% | -13006.2% | -13726.4% | -12093.8% | -11630.6% |
| **Net Profit Margin** | -15526.4% | -15021.1% | -14123.4% | -15861.4% | -14062.5% | -13360.3% | -10416.4% | -10188.2% |
| Return on Equity (ROE) | -199.7% | -184.3% | -624.8% | -- | -- | -- | -- | -- |
| Return on Assets (ROA) | -144.9% | -112.1% | -154.6% | -241.4% | -286.7% | -391.5% | -243.4% | -201.2% |
| Current Ratio | 2.75x | 2.11x | 1.01x | 0.53x | 0.64x | 0.10x | 0.26x | 0.44x |
| Quick Ratio | 2.60x | 2.01x | 0.96x | 0.49x | 0.60x | 0.08x | 0.23x | 0.42x |
| Debt to Equity | 0.24x | 0.51x | 2.15x | -- | -- | -- | -- | -- |
| **Revenue Growth (YoY)** | -15.4% | +4.0% | +37.5% | -53.3% | -25.7% | -50.0% | -60.0% | -30.8% |

## Related Companies

[AMZN (Amazon.com, Inc.)](https://convexityos.com/fundamentals/AMZN), [WMT (Walmart Inc.)](https://convexityos.com/fundamentals/WMT), [AAPL (Apple Inc.)](https://convexityos.com/fundamentals/AAPL), [GOOG (Alphabet Inc.)](https://convexityos.com/fundamentals/GOOG), [UNH (UnitedHealth Group Incorporated)](https://convexityos.com/fundamentals/UNH), [CVS (CVS HEALTH Corp)](https://convexityos.com/fundamentals/CVS), [MCK (McKESSON CORPORATION)](https://convexityos.com/fundamentals/MCK), [BRK-A (Berkshire Hathaway Inc.)](https://convexityos.com/fundamentals/BRK-A)

---

## About Convexity

Published by [Convexity](https://convexityos.com/), a primary-source financial intelligence terminal built on SEC EDGAR filings, XBRL financial statements, options, macro data, and cited AI research. Free tier with no card and published prices at https://convexityos.com/pricing; Streamable HTTP MCP server at https://convexityos.com/mcp; full site index at https://convexityos.com/llms.txt.
